Gene Therapy INDs In China: Five Things To Consider

18 Sep 2018

• By Brian Yang

China is overtaking the US as the largest cell development market, with over 2,300 registered clinical trials.

China CDE's senior reviewer Huang Hongyun on cell therapy development during China Rare Disease Summit, 9/15/18 • Source: The Pink Sheet

More from China

More from Asia